|
|
"Low Level Revision 1 1.4
|
Drs. M. Miyamoto and K. Sakamoto of
Tohoku University School of Medicine report on TBI effects on mice tumors (1987) that: "The effects of low dose (0.05-1.0 Gy) of total body irradiation (TBI) on non-tumor bearing and tumor bearing mice were investigated. Mice received TBI of 0.1 Gy during 6-12 hours before tumor cell inoculation demonstrated to need larger number of tumor cells (approximately 2.5 times) for 50 per cent tumor incidence, compared to recipient mice not to receive TBI. On the other hand, in tumor bearing mice given 0.1 Gy of TBI, only tumor cell killing effect was not detected, however enhancement of tumor cell killing effect and prolonged growth delay were observed when tumor bearing mice were treated with 0.1 Gy of TBI in combined with local irradiation on tumors, especially cell killing effect was remarkable in dose range over 6 Gy of local exposure. The mechanism of the effect of 0.1 Gy TBI is considered to be host mediated reactions from the other of our experimental results." [Table 1, Table 2, Table 3, Table 4] [Editors Note: The following tables and figures from Miyamoto and Sakamoto
1987 document their biopositive and anti tumor effects of low-dose radiation. These
results have been confirmed, by their later work and others. Note also: these results have
been applied to successfully treat cancer in humans in the decade since these results were
published. See Section 1.7. Note also: the committed radiation protection bias and control
of radiation science policy has constrained research to confirm and apply these results,
potentially affecting millions of persons with cancer that may have lived with the success
of these low-dose radiation therapies. See also the following 1987 summary by Sakamoto and
Miyamoto.] |
|
RSH > Documents
> RSH Data Docs > 1.4 > Miyamoto 1987
|
For more information please contact the RSH President Jim Muckerheide
For website problems please contact the Webmaster |